Key Allogeneic Advantages Driving the Commercialization of "Off-the-Shelf" MSC Products
The strategic development of Mesenchymal Stem Cells favors Allogeneic Advantages—cells derived from healthy donors—over autologous (patient-derived) therapies. Allogeneic products can be manufactured in large, standardized batches, allowing for extensive quality control and the creation of "off-the-shelf" inventories. This is vital for treating acute conditions like stroke or...
0 Comments 0 Shares 28 Views 0 Reviews